| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/31/2006 | WO2006089478A1 The use of isoscutellarin for the manufacture of medicine |
| 08/31/2006 | WO2006072393A3 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 08/31/2006 | WO2006069242A3 Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related?disorders |
| 08/31/2006 | WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 08/31/2006 | US20060194947 Peptide gap junction modulators |
| 08/31/2006 | US20060194872 Diamine derivative, production process therefor and antioxidant |
| 08/31/2006 | US20060194868 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and /or congestive heart failure |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194860 Pharmaceutical compositions containing aryl or heteroaryl azolylcarbinol compounds |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194836 Novel compounds having 4-pyridylalkylthio group as substituent |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194822 Treatment for renal fibrosis |
| 08/31/2006 | US20060194819 Activation specific inhibitors of nf-kb and method of treating inflammatory processes in cardio-vascular diseases |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194795 Platelet ADP receptor inhibitors |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060194772 Triamide-substituted heterobicyclic compounds |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194742 Pyrane derivatives as both ACE- and NEP-inhibitors |
| 08/31/2006 | US20060194734 Cardiac muscle function and manipulation |
| 08/31/2006 | US20060194727 Prevention and reduction of blood loss |
| 08/31/2006 | US20060194338 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060193929 Method for treating or preventing symptoms associated with menopause |
| 08/31/2006 | US20060193851 Human anti-factor IX/IXa antibodies |
| 08/31/2006 | US20060193840 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 08/31/2006 | US20060193835 Treatment of congestive heart failure |
| 08/31/2006 | US20060193823 Hydrolytically degradable carbamate derivatives of poly (Ethylene Glycol) |
| 08/31/2006 | CA2633940A1 Preventive or therapeutic agent for cardiac dysfunction or myocardial injury caused by ischemia or ischemia reperfusion |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2599301A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| 08/31/2006 | CA2599164A1 Novel pyridine derivatives as potassium ion channel openers |
| 08/31/2006 | CA2598829A1 Plant extracts and methods and uses therefore |
| 08/31/2006 | CA2598289A1 Tropoelastin for promoting endothelial cell adhesion or migration |
| 08/31/2006 | CA2598016A1 Amorphous lercanidipine hydrochloride |
| 08/30/2006 | EP1695983A2 Glucagon-like peptide-1 analogs |
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |
| 08/30/2006 | EP1695977A2 Spiro [isobenzofuran-1,4'piperidin]-3-ones and 3H-spiroisobenzofuran-1, 4'-piperidines |
| 08/30/2006 | EP1695974A1 1,8-Naphthyridines as CRF antagonists |
| 08/30/2006 | EP1695962A1 Cyclic amine derivative having heteroaryl ring |
| 08/30/2006 | EP1695959A1 Compouds and methods for the inhibition of the expression of VCAM-1 |
| 08/30/2006 | EP1695719A1 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 08/30/2006 | EP1695710A1 Crystalline form beta-d fo the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 08/30/2006 | EP1695709A1 Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 08/30/2006 | EP1695706A1 Medicinal compositions and combinations |
| 08/30/2006 | EP1695698A1 Anti-angiogene compositions and methods of use |
| 08/30/2006 | EP1695697A1 Anti-angiogenic compositions and methods of use |
| 08/30/2006 | EP1694645A1 Amlodipine gentisate and a method of its preparation |
| 08/30/2006 | EP1694292A2 Therapeutic foam comprising a sclerosing solution |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1490056B1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 08/30/2006 | EP1436292B1 5-methoxy-8-aryl-¬1,2,4|triazolo¬1,5-a|pyridine derivatives as adenosine receptor antagonists |
| 08/30/2006 | EP1425280B1 Hetero-bicyclic crf antagonists |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1412343B1 Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 08/30/2006 | EP1345924B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | EP1272183B1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 08/30/2006 | EP1254260B1 Methods for diagnosing and treating heart disease |
| 08/30/2006 | EP1202953B1 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/30/2006 | EP1066042B1 Steroidal saponins for treating alzheimer's disease |
| 08/30/2006 | EP1020439B1 Cetp activity inhibitors |
| 08/30/2006 | CN1826340A Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/30/2006 | CN1826321A Quinolone derivative or its salt |
| 08/30/2006 | CN1826122A Oxidized phospholipids and application in atherosclerosis treatment thereof |
| 08/30/2006 | CN1826104A Methods of inhibiting vascular permeability and apoptosis |
| 08/30/2006 | CN1824647A Crystal of (+-)2-(dimethylamino)-1-{[o-(m-methoxyphenethyl)phenoxy]methyl}ethyl hydrogen succinate hydrochloride |
| 08/30/2006 | CN1824324A Medicine for repairing and treating viscera injury |
| 08/30/2006 | CN1824320A Medicinal composition containing calcium passage paralysor and B family vitamin and its use |
| 08/30/2006 | CN1824315A Synergistic therapeutic compositions and methods |
| 08/30/2006 | CN1824312A Compound medicine for preventing and treating cardio vascular cerebral vascular disease and its application |
| 08/30/2006 | CN1824311A Preparation for the prophylaxis of restenosis |
| 08/30/2006 | CN1824294A Preparation technology of sarcosine peptide glycoside injection liquid |
| 08/30/2006 | CN1824279A Medicine and fool dual purpose Chinese medicinal product for prevonting and treating dizzy head and sision and its manufacturing method |
| 08/30/2006 | CN1824257A Uterus stabilizing pressure reducing medicinal preparation and its new peparation method |
| 08/30/2006 | CN1824252A Astragalus leech network ressel freeing capsule |
| 08/30/2006 | CN1824251A Chinese medicinal plaster of infrared energy ceramic powder for promoting blood circulation and its preparation method |
| 08/30/2006 | CN1824246A Medicinal film vest medicinal film plaster for treating coronary heart disease stenocardia and preventing myocardial infaction and its preparation method |
| 08/30/2006 | CN1824183A Eggplant millet pill for blood quickening and blood dissipation and its preparation method |
| 08/30/2006 | CN1824177A Medicinal composition for treating hypertension, its preparation method and use |
| 08/30/2006 | CN1824174A Medicinal preparation made of gastrodia and uncaria |
| 08/30/2006 | CN1824172A Gastrodia freeze dried powder injection for intravenous injection and its preparation technology |
| 08/30/2006 | CN1824163A Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating palmus and its manufacturing method |
| 08/30/2006 | CN1824159A Heart boosting pulse restoring tablet and its preparation method |
| 08/30/2006 | CN1824136A Preparation method of high allicin garlic powder capsule |
| 08/30/2006 | CN1824135A Medicinal preparation for treating cardio and cerebral vascular disease and its preparation method and quality control method |
| 08/30/2006 | CN1824130A Medicien capable of preventing and treating cardiopathy, osteopathia, high blool pressure, diabetes etc. multi kind disease |
| 08/30/2006 | CN1824020A Medicine for treating coronary heart disease and its preparation method |
| 08/30/2006 | CN1824014A Blood pressure reducing preparation and its making method |
| 08/30/2006 | CN1824008A Heart nourishig capsule and its preparation method |
| 08/30/2006 | CN1823978A Hemorrhoid blood stopping agent and its preparation method |
| 08/30/2006 | CN1823960A Traditional Chinese medicine for treating hemorrhoid |
| 08/30/2006 | CN1823959A Heart vessel free flowing dispersion tablet and its preparation method |
| 08/30/2006 | CN1823952A Stasis expelling vessel freeing drip pill |